ACSS2 and glioblastoma: The upregulation of acyl-CoA synthetase short chain family member 2 (ACSS2), which converts acetate to acetyl-CoA, is typical in GBM and it is correlated to a worst prognosis in GBM patients (Comerford et al., 2014; Mashimo et al., 2014).